Bloodletting

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 30.12.2021

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Classic bleeding procedure. Rheological measure for isovolaemic dilution.

Effects
This section has been translated automatically.

The extracted volume is replaced by reabsorption from the tissue. This decongestion improves the microcirculation.

Indication
This section has been translated automatically.

Conventional medicine indicated for porphyria cutanea tarda and polycythemia vera. Naturopathically also in overfed patients, metabolic diseases such as obesity, gout, diabetes mellitus, hyperlipidemia, diseases with a Hct > 40% and a Hb of > 145 g/l, hemochromatosis. Hypertension. Also in cardiovascular diseases, respiratory problems, shortness of breath, dizziness, sweating and circulatory disorders of the brain. Venous stasis corresponding to chronic venous insufficiency Venous insufficiency, chronic.

Implementation
This section has been translated automatically.

Collection of up to 100-300 ml of blood 1-2 times/week from the arm vein, control of the crit. For porphyria cutanea tarda and polycythaemia vera up to 500 ml/week.

Undesirable effects
This section has been translated automatically.

vasovagal reaction - Caution: Lie patient down! Headache, shingling, haematoma locally at the blood collection site, infection of the puncture site.

Contraindication
This section has been translated automatically.

Anemia, dehydration, acute diarrhea, hypotension. Physically debilitated patients.age > 80 yearscoronary heart disease, during mensturation.

Notice. Bloodletting therapy is indicated for full types, not for empty types.

Authors

Last updated on: 30.12.2021